X

Enquire Now

Policies, Compliances & Announcements

UPL Ltd has informed BSE and NSE that its wholly owned subsidiary, in Mauritius, UPL Corporation Limited ("UPL Corp"), has signed a definitive agreement with Platform Specialty Products Corporation (NYSE:PAH) to acquire Arysta LifeScience Inc. and its subsidiaries (collectively "Arysta"), a global provider of innovative crop protection solutions, including BioSolutions and Seed Treatment, for approximately US$4.2 billion in cash consideration, subject to customary closing conditions and regulatory approvals.

DISCLAIMER

“UPL and its subsidiaries have made every attempt to ensure accuracy of the information provided on this website. However, this is a global webpage with access to different geographies for wider reach and greater awareness of UPL. In the course of doing the same, UPL has used Google translator plugin to convert the language of this website from English to select regional languages.

UPL therefore, does not accept any responsibility or liability on the nature, standard or the accuracy of the translation and cannot take responsibility for any type of inaccurate contextual meaning in the event of a mismatch from English to a regional language.”